| Target Price | kr295.80 |
| Price | kr259.40 |
| Potential |
14.03%
register free of charge
|
| Number of Estimates | 19 |
|
19 Analysts have issued a price target Gjensidige Forsikring 2027 .
The average Gjensidige Forsikring target price is kr295.80.
This is
14.03%
register free of charge
kr337.05
29.93%
register free of charge
kr246.44
5.00%
register free of charge
|
|
| A rating was issued by 21 analysts: 10 Analysts recommend Gjensidige Forsikring to buy, 9 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Gjensidige Forsikring stock has an average upside potential 2027 of
14.03%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion kr | 42.96 | 46.30 |
| 10.68% | 7.78% | |
| Net Margin | 15.26% | 16.91% |
| 15.24% | 10.79% |
10 Analysts have issued a sales forecast Gjensidige Forsikring 2026 . The average Gjensidige Forsikring sales estimate is
This results in the following potential growth metrics:
17 Gjensidige Forsikring Analysts have issued a net profit forecast 2026. The average Gjensidige Forsikring net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share kr | 13.11 | 15.66 |
| 27.53% | 19.45% | |
| P/E | 16.57 | |
| EV/Sales | 2.83 |
17 Analysts have issued a Gjensidige Forsikring forecast for earnings per share. The average Gjensidige Forsikring EPS is
This results in the following potential growth metrics and future valuations:
Gjensidige Forsikring...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


